Category Archives: Token Generating Events (TGEs)
Jaron Lukasiewicz joins as Strategic Advisor in advance of September Token Sale
Zug, Switzerland and Boston, MA — August 11, 2017
Ambrosus, the world’s first trusted blockchain-based ecosystem for the supply chain, today announced a partnership with pharmaceutical pioneer Trek Therapeutics, PBC (Trek) to apply integrated sensors coupled with blockchain-based technology to pharmaceutical drug manufacturing in Trek’s clinical development program. This announcement comes as blockchain industry heavyweight Jaron Lukasiewicz joins Ambrosus as Strategic Advisor.
Combining high-tech sensors, blockchain, and powered by smart contracts, Ambrosus is building the world’s first publicly-verifiable, community-driven ecosystem to ensure the quality, safety, and origins of essential products, such as medicine, food and commodities. As part of the collaboration, Ambrosus will conduct pilot projects with Trek to monitor the quality, safety and integrity of all stages of the pharmaceutical manufacturing process.
Trek Co-founder and CEO Dr. Ann Kwong said,
“Currently the pharmaceutical manufacturing process is highly regulated by pharmaceutical manufacturers and by regulatory authorities in an extremely labor-intensive and expensive manner. We hope to partner with Ambrosus to create a continuous monitoring and tracking system that will be less labor intensive, less expensive, and more transparent to all parties with a stake in quality pharmaceutical manufacturing. Our goal is to develop a system that is robust enough that Trek can submit data to support our manufacturing application for regulatory approval of our drugs from the FDA and EMA authorities.”
“Additionally, patients currently have no way to ascertain the quality of the medicines they ingest. Trek believes it is important to be able to demonstrate to patients that while our drugs are affordable, they’re also of the highest quality,”
Dr Kwong added.
Ambrosus Co-Founder and CEO Angel Versetti said,
“Following the successful implementation of the Ambrosus protocol in global food supply chains, we are delighted to now apply our blockchain protocol to help ensure the quality, safety and integrity of another vitally important product – pharmaceuticals.”
Trek Therapeutics, PBC is a privately-held, public-benefit corporation developing treatments for serious infections. Its mission is to provide cost-effective, affordable, and accessible medicines to treat patients that suffer from infectious diseases and commercialize them for global populations. Since the company’s founding in 2014, Trek has raised US$10M in Series A funding. Trek’s management team and board of directors is comprised of seasoned drug-development executives from Vertex, Schering Plough/Merck, Pharmasset/Gilead, Bristol-Myers Squibb, Roche, Celgene Global Health, Idenix, and Genzyme.
“Trek is focused on developing safe, novel medicines for infectious diseases at affordable and accessible prices. The pharmaceutical supply chain encompasses many phases and a multitude of stakeholders, requiring responsible parties to seek new methods of guaranteeing the quality and integrity of critical products. As Trek continues their mission to develop pharmaceuticals for budget-constrained patients across North America and Europe, our partnership will help to develop protocols to provide transparency and quality assurance during each phase of the process,”
As part of the pilot projects, Ambrosus’s protocol will work to verify and track the entire manufacturing chain from the primary chemical starting materials through multiple steps of synthesis, purification, and verification of the active pharmaceutical ingredient (API); followed by formulation of the API into drug product; packaging, labeling, storage, and shipping to clinical trial sites.
“Backed by a superb core team of developers, advisors, and researchers, Ambrosus’ protocol will provide the transparency necessary in our manufacturing process to help ensure the integrity of supply chains. With our commitment to providing affordable high quality medicine, we believe this partnership could revolutionize the pharmaceutical industry quality control of manufacturing at every stage from plant to patient,”
Dr. Kwong said.
Joining the Ambrosus team as an Advisor is blockchain luminary Jaron Lukasiewicz. Speaking on the announcement, Versetti added: “Ambrosus is excited to welcome Jaron Lukasiewicz as our Strategic Advisor. As a highly-respected blockchain industry figure we are eager to utilize his invaluable expertise as we lead up to our September token sale and beyond.”
Jaron Lukasiewicz has been a notable bitcoin and blockchain industry figurehead since 2012. Lukasiewicz founded and served as CEO of Coinsetter, a New York City-based bitcoin exchange, which was acquired by Kraken, the world’s largest digital asset exchange in Euro volume, in January 2016. The sale was, at the time, the largest M&A deal in bitcoin history. Lukasiewicz also served as CEO of Cavirtex (Canadian Virtual Exchange), the oldest and largest Canadian bitcoin exchange, which was also acquired by Kraken in 2016. Since the acquisition, Lukasiewicz has served as an active advisor to several blockchain companies and blockchain investment funds in addition to his role as the CEO of WRKFLOW.
Jaron Lukasiewicz said:
“I am excited about the future of the Ambrosus project and equally the team behind it, who together carries decades of experience in their target markets. Ambrosus can become a fundamental technology utilized in sectors ranging from food to pharma, stretching the boundaries of what blockchain technology can accomplish in real world applications.”
Founded in 2016 by Angel Versetti and Dr Stefan Meyer, Ambrosus is the world’s first publicly-verifiable and community-driven system to assure the quality, safety, and origins of products such as food and pharmaceuticals. Officially endorsed by SQS (Swiss Quality and Safety Association), Ambrosus boasts the support of significant global bodies and associations including the United Nations, EPFL, the Crypto Valley Association, and financial backing from the Government of the Canton of Vaud, Switzerland.
With an underlying ERC20-standard token called Amber, Ambrosus will complete a tokensale in September 2017 that will serve to fuel the development of the Ambrosus ecosystem.
For more information, or to see technical papers for Ambrosus sensors, marketplace and non invasive analytics, visit www.ambrosus.com.
Trek Therapeutics, PBC is a private, clinical stage public benefit corporation developing treatments for serious infections. Its mission is to profitably develop affordable and accessible medicines to treat infectious diseases and to commercialize them for global populations starting with hepatitis C virus (HCV) infection. Its commercial strategy is to price their treatment regimen low enough to include the majority of patients infected with HCV who cannot afford the expensive treatments available today. Trek is currently raising Series B financing to support the completion of its Phase 2a program and initiate its Phase 2b studies. Trek is examining the possibility of a listing on the Euronext Growth and other markets. For further information, please visit http://www.trektx.com/.
Disrupting A $200 BILLION Market | Bowhead Health ICO
ICO Summit is 15th September @ 8:30am – 5:00pm.
It it arranged in Zurich, Switzerland.
TokenMarket CEO, Mr. Ransu Salovaara, will participate in State of ICO Market – Cutting through the Hype panel.
Realist News update – ICOs On Track To Raise $1.7B As Firms Ignore SEC’s “Tokens Are Securities” Ruling
Realist News update – ICOs On Track To Raise $1.7B As Firms Ignore SEC’s “Tokens Are Securities” Ruling
BitJob is the first decentralized peer to peer student marketplace for online short term jobs, powered by the Ethereum blockchain. Aimed at revolutionising the way students make a living and gain occupational experience while still studying, BitJob will give students the opportunity to receive immediate payment for their skills from professional employers whilst enriching their dynamic résumé, anytime and from anywhere.
Every pre-sale contributor will receive a new hardware TREZOR Wallet for free.
Find out more at: bitjob.io
bitJob Crowdsale opens on 2. Aug 2017.
Decentralized Student Marketplace for Online Jobs
Please note that time might not be exact. Check the project ICO page for up-to-date minute estimations.
Crypto Blood Update: REXmls ICO Disaster! And My Take on The BTC Fork Today!
Source: Crypto Blood
Rivetz Corp., a company founded in 2013, is about to launch their crowdsale for Rivetz Token (July 25, 2017) – a decentralized, mobile security token that will be used to access the cyber security solutions and other capabilities provided by this first mover.
What is the Greatest Threat to Companies today?
The survival of companies is threatened by various factors today. To name a few: lone wolf attacks, losing competitive advantage, changes in the regulatory environment, high costs associated with unconstrained hiring, lack of innovation, bad management, natural disasters and market instability.
The list certainly doesn’t stop there, but what can be deemed the greatest threat to every single company out there today?
In my opinion, cyber crime – the use of computers or the internet to commit and/or facilitate criminal activities – is the biggest threat faced by every single company today. This is regardless of whether they like to admit it or not.
To get an idea of the magnitude of the problem we’re facing: The global economy lost in excess of $450 billion due to cyber crime in 2016 alone. According to Juniper Research, this figure is estimated to reach in excess of $2 trillion dollars by 2019. Others such as Cybersecurity Ventures places the figure much higher – in excess of $6 trillion by 2021!
If the above is not shocking enough, a survey that was done by specialist insurer, Hiscox, revealed that less than half of the businesses in Germany, the U.K. and U.S. are ready to deal with cyber crime.
Furthermore, many businesses who think they are prepared, are not really prepared. They spent millions of dollars on outdated solutions such as firewalls, passwords and virtual private networks – all cyber security solutions that are no longer effective in the prevention of cyber crime.
All of these solutions assume that “the edge of the network is the network perimeter. This makes it too easy for non-authenticated users to probe and hack systems” (Rivetz White Paper, June 29, 2017, p.4).
What can be done to effectively fight against this growing threat?
You’ve got to love the approach proposed by Rivetz when it comes to data protection and information assurance (IA). Break the dependence on legacy solutions when it comes to cyber security – such as a password as a last line of defense – by expanding “the edge of security to the screen of the device” (Rivetz White Paper, June 29, 2017, p.4).
Accomplish this by utilizing the Trusted Execution Environment (TEE) – a vault like hardware platform that is present in each device – to make changes that cannot be altered nor observed by the processor. Use this trusted execution environment, not only to secure and process sensitive data, but also to guarantee information assurance (IA), including transaction assurance.
Build a network in order to improve the data protection capabilities of the devices. The Global Attestation and Identity Network being built by Rivetz, which is fueled by the Rivetz Token (RvT), will constantly monitor, measure and record the state of the device in terms of its integrity and health.
Rivetz plans to fully integrate their model into the Bitcoin (BTC) and Ethereum (ETH) blockchains at the end of the day – a move that will decentralize the approach to cyber security and information assurance (IA). They have already prototyped the technological capability required to make it work, but some of the core capabilities still need to be rolled out. This will happen in step with the roll out of the mainstream blockchain roadmap.
Ultimately each Rivetz Token (RvT) will serve as a “key” to unlock the cyber security controls enabled by Rivetz.
Why should you participate in the Rivetz ICO?
The Rivetz ICO or crowdsale kicks off on July 25, 2017. They are hoping to sell a maximum of 70 million RvT tokens (maximum $50,000,000) during the crowdsale – 35% of the total supply of 200 million RvT tokens.
Here are reasons why you should participate:
Early Bird Bonus
Early birds will receive a 20% bonus. Why potentially pay more later when you can get in cheaper now, right?
Massive Market and Growth Potential
Given that for the most part, no provable security exists in terms of the end-point devices being used in the Internet of Things (IoT), Rivetz aims to change the status quo.
If Rivetz succeeds, IoT devices will leave the premises of manufacturers with security in the box so to speak. This means that the market targeted by Rivetz will include all Internet of Things devices, including mobile devices. This is a massive market!
The number of IoT devices is expected to hit the 20 billion mark this year (20 Billion Connected Internet of Things Devices in 2017, IHS Markit Says). This while it is estimated to reach 200 billion devices by 2020 (Intel Infographic) – an expected increase of 900% in about 3 years!
Can you imagine the perks of getting in at the ground floor in terms of this potential revenue growth?
Regulatory Compliance Data Protection Laws
The cyber security and information assurance solutions built by Rivetz should make it easier and more cost-effective than ever for businesses to comply with data protection laws, including compliance with the General Data Protection Regulation (GDPR) (Regulation (EU) 2016/679) and California S.B. 1386.
GDPR compliance will be compulsory from May 25, 2018 and forward. Love it or hate it – all signs are there that data protection laws are here to stay.
Get in during the Rivetz ICO – and chances are that your business might benefit from more than just discounted RvT tokens. If you ask nicely, they might throw in some promotional RvT tokens.
First Mover – Cyber Security Solutions – Blockchain Technology
Rivetz is a “first mover” in terms of cyber security solutions built by utilizing blockchain technologies. This provides them with a competitive advantage to at least some extent, especially considering that they have filed at least one patent to protect their intellectual property.
Experience and Leadership – Blockchain Technologies and Trusted Computing
Rivetz Corp. is a relatively young company (founded in 2013), but the Rivetz team is an established team made up of members who have decades of experience when it comes to blockchain technologies and trusted computing. The team includes among others, Steven and Michael Sprague (featured below).
Non-blockchain capabilities currently offered by Rivetz include “multifactor authentication, embedded authentication, file encryption and secure messaging” (Rivetz White Paper, June 29, 2017, p.5). In addition, Rivetz currently has operational technology in place that is compatible with 500 million+ mobile phones.
Contracted Revenue, Other Revenue Streams and New Markets
The Rivetz team has managed to secure in excess of a million dollars in contracted revenue from the U.S. government. This is a drop in the bucket, but provides a “safety net” and the potential for more down the road.
Other revenue streams will include revenue generated from metered access to token-enabled services and other capabilities (see below) – something that should help to open new markets to serve the future $40bn Internet of Things market.
The Rivetz team is in the process of developing various token-enabled services. They are for one working on a means to provide support for secure micro-payment for these services and capabilities. All of these services will only be accessible via RvT tokens – the proverbial “keys” to start the “engine.”
General Purpose Use Cases
The Rivetz solution will provide general purpose use cases across the spectrum, including but not limited to: assured transaction instructions for e-commerce solutions, multisig wallets, assured instructions for cryptocurrency wallets (online and offline), multi-factor authentication with provable cybersecurity controls and token projection of client private keys and process. Details on this can be seen on pages 16-17 and 25-26 of the Rivetz White Paper.
Rivetz’s strategic relationship with Trustonic, leaders in mobility and security, give access to more than a billion devices that are already in the field so to speak. Furthermore, the Rivetz team is hard at work to establish new strategic relationships. They have initiated discussions with Qualcomm – world leader in 3G and next-generation mobile technologies, Intel and others.
If successful, Rivetz will not only enjoy greater support for their commercial TEE solutions, but get access to even more devices.
Don’t be too surprised when Rivetz becomes the undisputed leader in trusted computing. The Rivetz ICO offers a golden opportunity to get in at the ground floor and share in their potential failures and successes.
The Bowhead Tokensale is not available for US or Canadian citizens or residents.